person · Reporting owner
Peterson Robert Charles
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| biote Corp.BTMD · Entity 7156 | Director · Interim CEO | June 12, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
biote Corp.
Report date June 12, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.46 · Expires 2036-06-11 | Direct | 206,746 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 206,746 · Balance 206,746 F1: 25% of the shares subject to the option shall vest on June 12, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to the option shall vest on June 12, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2026 Filed Jun 16, 2026 21:15 UTC | biote Corp. BTMD · Entity 7156 | GrantStock Options (Right to buy) · Derivative | 206,746 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0002005188-26-000004 · primarydocument.xml · derivative · entry 1 Peterson Robert Charles · CIK 0002005188 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,746 Underlying: Class A Common Stock · 206,746 shares Expires 2036-06-11 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on June 12, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 17:19 UTC | biote Corp. BTMD · Entity 7156 | GrantEmployee Stock Option (Right to Buy) · Derivative | 107,169 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0002005188-26-000002 · primarydocument.xml · derivative · entry 1 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,169 Underlying: Class A Common Stock · 107,169 shares Expires 2036-03-31 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 1, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:34 UTC | biote Corp. BTMD · Entity 7156 | GrantEmployee Stock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001562180-25-002907 · primarydocument.xml · derivative · entry 1 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Class A Common Stock · 350,000 shares Expires 2035-03-31 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 1, 2026, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| September 09, 2024 Filed Sep 11, 2024 19:32 UTC | biote Corp. BTMD · Entity 7156 | SaleClass A Common Stock | 32,874 | $6.20 | $203,848.39 |
DisclosureSEC source: 0001562180-24-006766 · primarydocument.xml · nonDerivative · entry 1 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.15 USD to $6.345 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| July 09, 2024 Filed Jul 10, 2024 20:31 UTC | biote Corp. BTMD · Entity 7156 | SaleClass A Common Stock | 11,376 | $7.57 | $86,084.47 |
DisclosureSEC source: 0001562180-24-005670 · primarydocument.xml · nonDerivative · entry 2 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,874 Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 20:31 UTC | biote Corp. BTMD · Entity 7156 | Exercise / conversionRestricted Stock Unit · Derivative | 44,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005670 · primarydocument.xml · derivative · entry 3 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 44,250 shares Expires 2024-07-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 20:31 UTC | biote Corp. BTMD · Entity 7156 | Exercise / conversionClass A Common Stock | 44,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005670 · primarydocument.xml · nonDerivative · entry 1 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 21:16 UTC | biote Corp. BTMD · Entity 7156 | GrantRestricted Stock Unit · Derivative | 44,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001035 · primarydocument.xml · derivative · entry 2 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,250 Underlying: Class A Common Stock · 44,250 shares Expires 2024-07-09 Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 21:16 UTC | biote Corp. BTMD · Entity 7156 | GrantEmployee Stock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001035 · primarydocument.xml · derivative · entry 1 Peterson Robert Charles · CIK 0002005188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Class A Common Stock · 400,000 shares Expires 2034-01-31 F1 · derivative.exercise_date: One-half (1/2) of the shares subject to the option vest on January 8, 2026, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.